MyMedR

Displaying all 11 publications

Abstract:

Sort:

Fulltext Electrospun novel nanocomposite comprising polyurethane integrated with ayurveda amla oil for bone tissue engineering

Jaganathan SK, Mani MP

An Acad Bras Cienc, 2020;92(1):e20180369.
PMID: 32236296 DOI: 10.1590/0001-3765202020180369

Ayurveda oil contains numerous source of biological constituents which plays an important role in reducing the pain relief caused during bone fracture. The aim of the study is to fabricate the polyurethane (PU) scaffold for bone tissue engineering added with ayurveda amla oil using electrospinning technique. Scanning Electron Microscopy (SEM) analysis showed that the fabricated nanocomposites showed reduced fiber diameter (758 ± 185.46 nm) than the pristine PU (890 ± 116.91 nm). Fourier Infrared Analysis (FTIR) revealed the existence of amla oil in the PU matrix by hydrogen bond formation. The contact angle results revealed the decreased wettability (116° ± 1.528) of the prepared nanocomposites compared to the pure PU (100° ± 0.5774). The incorporation of amla oil into the PU matrix improved the surface roughness. Further, the coagulation assay indicated that the addition of amla oil into PU delayed the blood clotting times and exhibited less toxic to red blood cells. Hence, the fabricated nanocomposites showed enhanced physicochemical and better blood compatibility parameters which may serve as a potential candidate for bone tissue engineering.
Fulltext Electrospinning synthesis and assessment of physicochemical properties and biocompatibility of cobalt nitrate fibers for wound healing applications

Jaganathan SK, Mani MP

An Acad Bras Cienc, 2019 Jul 29;91(3):e20180237.
PMID: 31365648 DOI: 10.1590/0001-3765201920180237

The aim of this study was to develop polyurethane (PU) wound dressing incorporated with cobalt nitrate using electrospinning technique. The morphology analysis revealed that the developed composites exhibited reduced fiber and pore diameter than the pristine PU. The electrospun membranes exhibited average porosity in the range of 67% - 71%. Energy-dispersive X-ray spectra (EDS) showed the presence of cobalt in the PU matrix. The interaction of cobalt nitrate with PU matrix was evident in Fourier transform infrared spectroscopy (FTIR) and thermogravimetric analysis (TGA). The contact angle results indicated the improved wettability of the prepared PU/cobalt nitrate composites (82° ± 2) than the pure PU (100° ± 1). The incorporation of cobalt nitrate into the PU matrix enhanced the surface roughness and mechanical strength as evident in the atomic force microscopy (AFM) and tensile test analysis. The blood compatibility assays revealed the anticoagulant nature of the prepared composites by displaying prolonged blood clotting time than the PU control. Further, the developed composite exhibited less toxicity nature as revealed in the hemolysis and cytotoxicity studies. It was observed that the PU wound dressing added with cobalt nitrate fibers exhibited enhanced physicochemical, better blood compatibility parameters and enhanced fibroblast proliferation rates which may serve as a potential candidate for wound dressings.
Fulltext Investigation of attributes of bourbon oil and cobalt nitrate constituted electrospun nanoscaffolds for blood compatibility and in vitro bone formation

Jaganathan SK, Mani MP

An Acad Bras Cienc, 2021;93(4):e20201140.
PMID: 34705943 DOI: 10.1590/0001-3765202120201140

This work aims to fabricate scaffold using polyurethane (PU) integrated with bourbon oil (BB) and cobalt nitrate (CoNO3) using the electrospinning technique. Morphological investigation signified a fall in fibre diameter for the PU/BB and PU/BB/CoNO3 nanocomposite than the PU. Spectral analysis indicated that BB and CoNO3 were added within the PU matrix. Wettability analysis insinuated an increase in the hydrophobic nature of the PU/BB than the PU. PU/BB/CoNO3 turned to be hydrophilic due to the integration of CoNO3 in the polymer matrix. Mechanical testing of PU/BB and PU/BB/CoNO3 indicated an increase in the tensile strength of the fabricated composites. Atomic force microscopy (AFM) portrayed the reduction in the roughness of the PU/BB and PU/BB/CoNO3 compared to the PU. The coagulation studies invariably documented the improved anticoagulant behaviour and less toxic nature of the PU/BB and PU/BB/CoNO3 in comparison with the PU. Further, bone mineralization testing revealed the enhanced apatite formation of the nanocomposite. Nanocomposite scaffolds with the fore-mentioned properties hold good potential for bone tissue engineering.
Fulltext Blood compatibility assessments of electrospun polyurethane nanocomposites blended with megni oil for tissue engineering applications

Jaganathan SK, Mani MP, Supriyanto E

An Acad Bras Cienc, 2019 Jun 19;91(2):e20190018.
PMID: 31241710 DOI: 10.1590/0001-3765201920190018

Tissue engineering holds as a prominent technique to repair or replace the damaged human parts to recreate its native function. In this research, a novel scaffold based on polyurethane (PU) comprising megni oil was electrospun for tissue engineering applications. The obtained polyurethane blended with megni oil nanofibers were characterized by scanning electron microscopy (SEM), fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), contact angle measurement and atomic force microscopy (AFM). Furthermore, the blood compatibility of the fabricated nanocomposites evaluated through activated prothrombin time (APTT), partial thromboplastin time (PT) and hemolysis assay to determine the anticoagulant nature. The morphological results showed that the fabricated nanocomposites showed reduced fiber size (789 ± 143.106 nm) than the pristine control (890 ± 116.91 nm). The interaction between PU and megni oil was identified by the hydrogen bond formation evident in the FTIR. The incorporation of megni oil in the PU decreased the wettability behavior (113.3° ± 1.528) and improved the surface roughness (646 nm). Preliminary evaluation of blood compatibility assessments was carried out using APTT, PT and hemolysis assay revealed the enhanced antithrombogenicity nature of the fabricated nanocomposites than the PU. Hence, we conclude that the fabricated new nanocomposite membrane with desirable characteristics which might find potential application in the tissue engineering applications.
Charting the microplastic menace: A bibliometric analysis of pollution in Malaysian mangroves and polypropylene bioaccumulation assessment in Anadara granosa

Mohan P, Shahul Hamid F

Mar Pollut Bull, 2024 Aug;205:116654.
PMID: 38959572 DOI: 10.1016/j.marpolbul.2024.116654

According to a bibliometric analysis, studies on microplastic pollution in Malaysia are still incomprehensive. This study found microplastic contamination in sediment (97 particles/kg) and water (10,963 particles/m3) samples from Malaysian mangroves. Sediment from Matang and water from Kuala Selangor recorded the highest microplastic concentrations at 140 ± 5.13 particles/kg and 13,350 ± 37.95 particles/m3, respectively. Fragmented, blue, rayon and particles of <0.1 mm microplastic were the most abundant in sediment and water. In an experiment of polypropylene microplastic uptakes, Anadara granosa was found to uptake more 0.1 mm fiber particles. The uptake is strongly correlated to the presence of microplastics in sediment and water. The estimated dietary intake (EDI) indicates that a consumer could ingest 507 microplastic particles/year by consuming contaminated A. granosa. Therefore, mitigating measures are crucial to safeguard aquatic systems and humans from microplastic pollution.
Fulltext Insufficiency fractures related to low-dose adefovir dipivoxil treatment for chronic hepatitis B

Poh F, Sing WH, Mohan PC

Med J Malaysia, 2015 Feb;70(1):38-41.
PMID: 26032529

We present a case of a 53-year-old woman who developed multifocal insufficiency fractures associated with adefovir dipivoxil (ADV) induced osteomalacia, including recurring metatarsal insufficiency fractures and a subtrochanteric femoral insufficiency fracture requiring surgical fixation. She had received low-dose ADV treatment for 59 months for chronic hepatitis B viral infection at the time of presentation with subtrochanteric fracture. Imaging evidence of multifocal insufficiency fractures and metabolic disease on background of hypophosphatemia is attributed to hypophosphatemic osteomalacia from adefovir-induced renal proximal tubular dysfunction. Radiologists and clinicians should be aware of the possibility of insufficiency fractures in patients receiving ADV therapy to avoid delayed diagnosis and progression of high-risk proximal femoral fractures.
Beneath the surface: Exploring microplastic intricacies in Anadara granosa

Mohan P, Shahul Hamid F, Furumai H, Nishikawa K

Mar Environ Res, 2024 Jul;199:106581.
PMID: 38878345 DOI: 10.1016/j.marenvres.2024.106581

Anadara granosa or blood cockles have been reported to be a candidate for biomonitoring agents due to their sedimentary nature and their nutrient uptake mechanisms. Yet, this bivalve is still regarded as a delicacy in Asian cuisine. Malaysia is the largest exporter of this sea product that contaminated cockles may also be experienced by the importing countries. However, the bioaccumulation of microplastics in A. granosa cultivated in Malaysia has not been extensively studied. It is crucial to comprehend the risk posed to humans by consuming A. granosa in their diet. Therefore, the purpose of this research is to investigate the levels of microplastic accumulation in A. granosa from major exporters in Peninsular Malaysia, to evaluate the associated risk of microplastics on the species, and to estimate daily human consumption of microplastics through the consumption of A. granosa. The abundance of microplastics was quantified through the use of a stereo microscope, and the polymer type was determined using FTIR and micro-FTIR. Findings from this investigation revealed that all samples of A. granosa were contaminated with microplastics, with the highest levels of accumulation found in bivalves collected from the west coast (0.26 ± 0.15 particles/g) of Peninsular Malaysia. Fragment and fiber microplastics, measuring between 0.05 and 0.1 mm in size, were found to be the most prevalent in A. granosa, with blue being the dominant identified colour and rayon being the most common polymer type. Microplastic risk assessment due to the presence of polyacrylate, polycarbonate (PC), and polymethyl methacrylate (PMMA) resulted in a high risk of contamination for A. granosa. It was further determined that the current estimated dietary intake (EDI) suggests that consumers of A. granosa uptake approximately 21.8-93.5 particles/person/year of microplastics. This study highlights that A. granosa accumulates microplastics, which could potentially result in bioaccumulation and biomagnification in humans through consumption.
Worldwide distribution and abundance of microplastic: How dire is the situation?

Shahul Hamid F, Bhatti MS, Anuar N, Anuar N, Mohan P, Periathamby A

Waste Manag Res, 2018 Oct;36(10):873-897.
PMID: 30103651 DOI: 10.1177/0734242X18785730

The widespread occurrence of microplastic has invaded the environment to an extent that it appears to be present throughout the globe. This review investigated the global abundance and distribution of microplastics in marine and freshwater ecosystems. Furthermore, the issues and challenges have been addressed for better findings in microplastics studies. Findings revealed that the accumulation of microplastics varies geographically, with locations, hydrodynamic conditions, environmental pressure, and time. From this review, it is crucial that proper regulations are proposed and implemented in order to reduce the occurrence of microplastics in the aquatic environment. Without appropriate law and regulations, microplastic pollution will eventually threaten human livelihood.
Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area

Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D, et al.

Healthcare (Basel), 2023 Feb 02;11(3).
PMID: 36767006 DOI: 10.3390/healthcare11030431

Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance: next-generation sequencing (NGS). This refined testing provides unprecedentedly precise diagnoses and permits the use of focused and highly personalized treatments. However, across regions globally, many cancer patients will continue to be denied the benefits of NGS as long as some of the yawning gaps in its implementation remain unattended. The challenges at the regional and national levels are linked because putting the solutions into effect is highly dependent on cooperation between regional- and national-level cooperation, which could be hindered by shortfalls in interpretation or understanding. The aim of the paper was to define and explore the necessary conditions for NGS and make recommendations for effective implementation based on extensive exchanges with policy makers and stakeholders. As a result, the European Alliance for Personalised Medicine (EAPM) developed a maturity framework structured around demand-side and supply-side issues to enable interested stakeholders in different countries to self-evaluate according to a common matrix. A questionnaire was designed to identify the current status of NGS implementation, and it was submitted to different experts in different institutions globally. This revealed significant variability in the different aspects of NGS uptake. Within different regions globally, to ensure those conditions are right, this can be improved by linking efforts made at the national level, where patients have needs and where care is delivered, and at the global level, where major policy initiatives in the health field are underway or in preparation, many of which offer direct or indirect pathways for building those conditions. In addition, in a period when consensus is still incomplete and catching up is needed at a political level to ensure rational allocation of resources-even within individual countries-to enable the best ways to make the necessary provisions for NGS, a key recommendation is to examine where closer links between national and regional actions could complement, support, and mutually reinforce efforts to improve the situation for patients.
Empowering quality data - the Gordian knot of bringing real innovation into healthcare system

Horgan D, Hamdi Y, Lal JA, Nyawira T, Meyer S, Kondji D, et al.

Diagnosis (Berl), 2023 May 01;10(2):140-157.
PMID: 36548810 DOI: 10.1515/dx-2022-0115

OBJECTIVES: The introduction of Personalised Medicine (PM) into healthcare systems could benefit from a clearer understanding of the distinct national and regional frameworks around the world. Recent engagement by international regulators on maximising the use of real-world evidence (RWE) has highlighted the scope for improving the exploitation of the treasure-trove of health data that is currently largely neglected in many countries. The European Alliance for Personalised Medicine (EAPM) led an international study aimed at identifying the current status of conditions.
METHODS: A literature review examined how far such frameworks exist, with a view to identifying conducive factors - and crucial gaps. This extensive review of key factors across 22 countries and 5 regions revealed a wide variety of attitudes, approaches, provisions and conditions, and permitted the construction of a comprehensive overview of the current status of PM. Based on seven key pillars identified from the literature review and expert panels, the data was quantified, and on the basis of further analysis, an index was developed to allow comparison country by country and region by region.
RESULTS: The results show that United States of America is leading according to overall outcome whereas Kenya scored the least in the overall outcome.
CONCLUSIONS: Still, common approaches exist that could help accelerate take-up of opportunities even in the less prosperous parts of the world.
Fulltext Fighting Cancer around the World: A Framework for Action

Horgan D, Mia R, Erhabor T, Hamdi Y, Dandara C, Lal JA, et al.

Healthcare (Basel), 2022 Oct 25;10(11).
PMID: 36360466 DOI: 10.3390/healthcare10112125

Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients' engagement, and efforts for a better understanding of cancer.

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links